Palvella Therapeutics, Inc. SEC filings PVLA
Palvella Therapeutics, Inc. has 816 filings in SEC EDGAR's recent list, going back to Aug 20, 2013. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Nov 6, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Jul 6, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 2, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 13, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 18, 2019 | Dec 31, 2018 |
| 10-K/A | Amended annual report | Apr 26, 2018 | Dec 31, 2016 |
| 10-K | Annual report | Mar 15, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 30, 2017 | Dec 31, 2016 |
| 10-K/A | Amended annual report | Jul 20, 2016 | Dec 31, 2015 |
| 10-K/A | Amended annual report | Apr 29, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 23, 2016 | Dec 31, 2015 |
| 10-K/A | Amended annual report | Apr 29, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 30, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Sep 12, 2014 | Jun 30, 2014 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PVLA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Wayne, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1583648
- Former names
- PIERIS PHARMACEUTICALS, INC. (until Dec 12, 2024); Marika Inc. (until Dec 18, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.